Literature DB >> 8561968

Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.

L H Claye1, H C Akunne, M D Davis, S DeMattos, K F Soliman.   

Abstract

In order to determine whether repeated cocaine administration produced persistent changes in dopamine (DA) receptor binding and release consistent with behavioral sensitization, rats were treated with either cocaine (25 mg/kg ip) or saline twice daily for 14 consecutive days followed by a 3-d withdrawal period. The DA transporter site was assayed using [3H]GBR 12935, whereas D1 and D2 sites were assayed using [3H]SCH 23390 and [3H]spiperone, respectively. The density (Bmax) of the DA transporter binding sites in the ST of the cocaine-treated group increased significantly (p < 0.05) over controls 3 d after the last injection, whereas the density of striatal D1 and D2 binding sites remained unchanged. The DA transporter in the nucleus accumbens (NA) was also studied with [3H]GBR 12935 and was unchanged following drug treatment. D1 and D2 binding parameters for the NA were not determined in this study. Furthermore, cocaine administration did not affect the affinities (Kd) of the radioligands used to label the transporter, D1, or D2 sites in any of the studies performed. In addition, striatal DA release was measured using in vivo microdialysis in anesthetized rats. Linear regression analysis on maximal decreases in DA release after apomorphine (0.02, 0.2, and 2.0 mg/kg sc) injection showed no difference in the functional capacity of the ST to modulate DA transmission between control and treated groups. Moreover, animals pretreated with cocaine showed a significant (p < 0.01) decrease in locomotor activity (LA) after a presynaptic, autoregulating dose of apomorphine (0.03 mg/kg sc) was given. These results suggests that the effects seen after repeated exposure to cocaine may be regulated, in part, by changes in striatal DA transporter binding site densities and not necessarily by DA-releasing mechanisms or D1 and D2 receptor modification.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561968     DOI: 10.1007/bf02740684

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  35 in total

1.  D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment.

Authors:  M Laruelle; G E Jaskiw; B K Lipska; B Kolachana; M F Casanova; J E Kleinman; D R Weinberger
Journal:  Brain Res       Date:  1992-03-13       Impact factor: 3.252

2.  Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights.

Authors:  R Lew; R Vaughan; R Simantov; A Wilson; M J Kuhar
Journal:  Synapse       Date:  1991-06       Impact factor: 2.562

3.  Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.

Authors:  S J Yi; K M Johnson
Journal:  Pharmacol Biochem Behav       Date:  1990-07       Impact factor: 3.533

4.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

5.  Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

Authors:  S H Snyder
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

Review 6.  Dopamine transporter: biochemistry, pharmacology and imaging.

Authors:  M J Kuhar; P M Sanchez-Roa; D F Wong; R F Dannals; D E Grigoriadis; R Lew; M Milberger
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

7.  Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior.

Authors:  S Zeigler; J Lipton; A Toga; G Ellison
Journal:  Brain Res       Date:  1991-06-21       Impact factor: 3.252

8.  Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.

Authors:  L G Sharpe; N S Pilotte; W M Mitchell; E B De Souza
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

9.  Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum.

Authors:  S Izenwasser; B M Cox
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

10.  Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.

Authors:  P Allard; K Eriksson; S B Ross; J O Marcusson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more
  8 in total

1.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

2.  Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.

Authors:  S R Tella; B Ladenheim; A M Andrews; S R Goldberg; J L Cadet
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 3.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

4.  One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter.

Authors:  Osnat Ben-Shahar; Justin M Moscarello; Aaron Ettenberg
Journal:  Brain Res       Date:  2006-05-19       Impact factor: 3.252

5.  Cocaine self-administration produces a persistent increase in dopamine D2 High receptors.

Authors:  Lisa A Briand; Shelly B Flagel; Philip Seeman; Terry E Robinson
Journal:  Eur Neuropsychopharmacol       Date:  2008-03-04       Impact factor: 4.600

6.  Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats.

Authors:  J W Grimm; Y Shaham; B T Hope
Journal:  Behav Pharmacol       Date:  2002-09       Impact factor: 2.293

7.  Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.

Authors:  Kirsten E Culver; Henry Szechtman; Beth Levant
Journal:  Eur J Pharmacol       Date:  2008-07-04       Impact factor: 4.432

8.  Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study.

Authors:  Guillaume Becker; Louis-Ferdinand Lespine; Mohamed Ali Bahri; Maria Elisa Serrano; Christian Lemaire; André Luxen; Ezio Tirelli; Alain Plenevaux
Journal:  Brain Commun       Date:  2021-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.